PE20121501A1 - Proceso para la elaboracion de compuestos organicos - Google Patents

Proceso para la elaboracion de compuestos organicos

Info

Publication number
PE20121501A1
PE20121501A1 PE2012000559A PE2012000559A PE20121501A1 PE 20121501 A1 PE20121501 A1 PE 20121501A1 PE 2012000559 A PE2012000559 A PE 2012000559A PE 2012000559 A PE2012000559 A PE 2012000559A PE 20121501 A1 PE20121501 A1 PE 20121501A1
Authority
PE
Peru
Prior art keywords
alkyl
elaboration
compound
formula
organic compounds
Prior art date
Application number
PE2012000559A
Other languages
English (en)
Spanish (es)
Inventor
Gottfried Sedelmeier
Florian Andreas Rampf
Dominique Grimler
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41716392&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20121501(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20121501A1 publication Critical patent/PE20121501A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/32Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/32Separation; Purification; Stabilisation; Use of additives
    • C07C253/34Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/50Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
PE2012000559A 2009-10-27 2010-10-25 Proceso para la elaboracion de compuestos organicos PE20121501A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09174264A EP2316821A1 (en) 2009-10-27 2009-10-27 Process for the manufacture of organic compounds

Publications (1)

Publication Number Publication Date
PE20121501A1 true PE20121501A1 (es) 2012-11-15

Family

ID=41716392

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2012000559A PE20121501A1 (es) 2009-10-27 2010-10-25 Proceso para la elaboracion de compuestos organicos

Country Status (24)

Country Link
US (1) US20120238761A1 (enExample)
EP (2) EP2316821A1 (enExample)
JP (1) JP2013508436A (enExample)
KR (1) KR20120098652A (enExample)
CN (1) CN102596899A (enExample)
AR (1) AR079104A1 (enExample)
AU (1) AU2010311636B2 (enExample)
BR (1) BR112012009815A2 (enExample)
CA (1) CA2777031A1 (enExample)
CL (1) CL2012001081A1 (enExample)
CO (1) CO6531487A2 (enExample)
EC (1) ECSP12011833A (enExample)
IL (1) IL219111A0 (enExample)
IN (1) IN2012DN03032A (enExample)
MA (1) MA33692B1 (enExample)
MX (1) MX2012005025A (enExample)
NZ (1) NZ599218A (enExample)
PE (1) PE20121501A1 (enExample)
PH (1) PH12012500677A1 (enExample)
RU (1) RU2012121591A (enExample)
TN (1) TN2012000154A1 (enExample)
TW (1) TW201124389A (enExample)
WO (1) WO2011051213A1 (enExample)
ZA (1) ZA201202490B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102321038B (zh) * 2011-07-11 2014-03-26 安徽省虹升生物科技有限公司 一种改进的制备缬沙坦方法
FR2981077B1 (fr) * 2011-10-11 2013-11-01 Michelin Soc Tech Methode pour preparer un melange maitre d'elastomere dienique et de silice
US10745363B2 (en) 2016-09-02 2020-08-18 Nanjing Noratech Pharmaceuticals Co., Ltd Crystal forms of valsartan disodium salt
CN110078640B (zh) * 2019-03-29 2022-04-05 浙江美诺华药物化学有限公司 一种缬沙坦中间体的合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874867A (en) 1987-05-22 1989-10-17 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
IL97219A (en) * 1990-02-19 1995-12-08 Ciba Geigy Ag Biphenyl substituted aliphatic amino compounds process for their preparation and pharmaceutical compositions containing them
JPH04297466A (ja) 1990-06-22 1992-10-21 Nippon Shinyaku Co Ltd テトラゾール誘導体及び医薬
GB9222700D0 (en) * 1992-10-29 1992-12-09 Smithkline Beecham Plc Chemical compounds
GB0222056D0 (en) 2002-09-23 2002-10-30 Novartis Ag Process for the manufacture of organic compounds
GB0316546D0 (en) * 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
ITMI20032267A1 (it) * 2003-11-21 2005-05-22 Dinamite Dipharma S P A In Forma A Bbreviata Diph Procdimento per la preparzione di valsartan e suoi intermedi
HRP20030965A2 (en) * 2003-11-24 2005-08-31 Belupo - Lijekovi I Kozmetika D.D. Process for production of (s)-n-pentanoyl-n-[[2'-(
EP1714963A1 (en) * 2005-04-19 2006-10-25 IPCA Laboratories Limited Process for the Preparation of Valsartan and its Intermediates
EP1926705B3 (en) * 2005-08-22 2010-09-15 Alembic Limited Process for preparing valsartan
EP2057132A2 (en) * 2006-07-03 2009-05-13 Aurobindo Pharma Limited Process for the preparation of the angiotensin ii antagonist valsartan
CN101450917B (zh) * 2007-12-06 2012-07-11 浙江海正药业股份有限公司 缬沙坦的合成方法
US7943794B2 (en) * 2008-02-13 2011-05-17 Ranbaxy Laboratories Limited Processes for the preparation of intermediates of valsartan

Also Published As

Publication number Publication date
RU2012121591A (ru) 2013-12-10
BR112012009815A2 (pt) 2016-10-18
EP2316821A1 (en) 2011-05-04
EP2493848A1 (en) 2012-09-05
CL2012001081A1 (es) 2013-06-14
IN2012DN03032A (enExample) 2015-07-31
CN102596899A (zh) 2012-07-18
JP2013508436A (ja) 2013-03-07
TW201124389A (en) 2011-07-16
AR079104A1 (es) 2011-12-28
AU2010311636A1 (en) 2012-05-03
MA33692B1 (fr) 2012-10-01
IL219111A0 (en) 2012-06-28
TN2012000154A1 (en) 2013-12-12
PH12012500677A1 (en) 2012-10-29
MX2012005025A (es) 2012-06-08
AU2010311636B2 (en) 2014-03-06
US20120238761A1 (en) 2012-09-20
KR20120098652A (ko) 2012-09-05
CO6531487A2 (es) 2012-09-28
ZA201202490B (en) 2012-12-27
NZ599218A (en) 2014-02-28
CA2777031A1 (en) 2011-05-05
WO2011051213A1 (en) 2011-05-05
ECSP12011833A (es) 2012-06-29

Similar Documents

Publication Publication Date Title
PE20070517A1 (es) Derivados de imidazol como agentes inhibidores de la sintasa de aldosterona y aromatasa
PH12012501000A1 (en) Novel tricyclic compounds
NI201000054A (es) Compuestos químicos.
CY1119218T1 (el) Αναστολεις διυδροπυριδοφθαλαζινονης της πολυμερασης της πολυαδενοσφωσφορικης ριβοζης (parp)
PE20151537A1 (es) Bis(difluorometil)pirazoles como fungicidas
CR20110049A (es) Derivados de benzazepina y su uso como antagonistas de histamina h3
ECSP088536A (es) DERIVADOS DE PIRIDO-, PIRAZO- Y PIRIMIDO-PIRIMIDINA COMO INHIBIDORES DE mTOR
CL2009001063A1 (es) Uso de una combinacion de un compuesto derivado de n-quinoliniloxifenil-n-fenilciclopropanodicarboxamida y un inhibidor de erbb seleccionado entre lapatinib, erlotinib, gefitinib, trastuzumab, cetuximab, para eltratamiento de canceres.
SV2010003617A (es) Fungicidas
CR20120635A (es) Compuestos heterocìclicos de nitrògeno ùtiles como inhibidores de pde10
PE20150230A1 (es) Nuevos diazaespirocicloalcanos y azaespirocicloalcanos
BRPI1012770B8 (pt) derivados de tiofeno
ECSP10010657A (es) Nuevos compuestos tricíclicos
PE20121695A1 (es) 5-alquinil-pirimidinas
CY1113131T1 (el) Τα παραγωγα ινδολης ως αγωνιστες υποδοχεων s1p1
PE20140858A1 (es) Derivados de piperidina como inhibidores de renina
PE20161396A1 (es) Compuesto heterociclico
PE20141678A1 (es) Indazol-3-carboxamidas y su uso como inhibidores de la ruta de senalizacion de wnt/b-catenina
EA201001359A1 (ru) Гетероциклические соединения в качестве ингибиторов cxcr2
PE20142461A1 (es) Moduladores del receptor de estrogeno y sus usos
UY29612A1 (es) Compuestos quimicos ii
EA200900945A1 (ru) Новый способ синтеза агомелатина
ES2421896T3 (es) Compuestos de aril-(imidazol)-metil-fenilo sustituidos como moduladores selectivos de los subtipos de receptores adrenérgicos alfa 2B y/o alfa 2C
AR076208A1 (es) Pirrolidindiona espiroheterociclicos para usar como pesticidas
EA200900946A1 (ru) Новый способ синтеза агомелатина

Legal Events

Date Code Title Description
FA Abandonment or withdrawal